Skip to main content
RNST
NYSE Finance

Renasant Q3 EPS Slips to $0.86, Board Authorizes New $175M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Bank Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$41.58
Mkt Cap
$3.801B
52W Low
$33.04
52W High
$44.54
52W Position info
26% above low
Off High info
6.6% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

RNST sits 26% above its 52-week low of $33.04.

Summary

Renasant earned $78.9 million, or $0.86 per diluted share, in Q3 2026 — down from $0.94 last quarter but up from $0.63 a year ago — and authorized a new $175.0 million share repurchase program.


Key Events · Earnings and Guidance · RNST

  • Q3 EPS Falls Sequentially to $0.86

    Net income was $78.9 million versus $87.1 million in Q2 2026 and $59.8 million a year ago; diluted and adjusted diluted EPS were both $0.86, down from $0.94 linked quarter.

  • New $175M Buyback Authorized

    The board approved a $175.0 million repurchase program effective October 27, 2026, in effect until the earlier of October 2027 or full use, replacing the program that expired in October 2026.

  • Loan Growth Outpaces Deposit Decline

    Loans rose $555.9 million (11.5% annualized) while deposits fell $73.2 million on $214.7 million of public fund outflows; short-term borrowings increased $491.3 million to fund the gap.

  • Credit Metrics Improve, One Credit Drives Losses

    Net charge-offs were $10.0 million, or 0.20% annualized, with 16 bps from a single credit; nonperforming loans fell to 0.89% of loans and criticized loans to 2.50%.


Analysis · RNST · Finance

Third-quarter net income fell to $78.9 million from $87.1 million in Q2, and diluted EPS slipped to $0.86 from $0.94, so the sequential earnings trend is down even though results are well above the year-ago $0.63. The offset is a balance sheet still growing: loans rose $555.9 million (11.5% annualized) and credit metrics improved, with nonperforming loans down to 0.89% of loans and criticized loans down to 2.50%. The board's new $175.0 million repurchase authorization, replacing the program that expired this month, puts a fresh capital-return commitment behind the stock after $42.6 million of buybacks in the quarter at a $41.05 average price.

How filings like this one have moved

In the 30 days to Oct 27, 2026, 29.9% of the 1374 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RNST was trading at $41.58 on NYSE in the Finance sector, with a market capitalization of approximately $3.8B. The 52-week trading range was $33.04 to $44.54. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RNST - Latest Insights

RNST
Oct 27, 2026, 4:31 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $41.58
Real-time Price: $41.58 info
Change: $0 (0%) info
Market Cap: $3.801B info
RNST
Oct 27, 2026, 4:30 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $41.58
Real-time Price: $41.58 info
Change: $0 (0%) info
Market Cap: $3.801B info
RNST
Aug 06, 2026, 3:59 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $43.37
Real-time Price: $41.58 info
Change: -$1.79 (-4%) info
Market Cap: $3.801B info
RNST
Jul 28, 2026, 4:37 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $43.89
Real-time Price: $41.58 info
Change: -$2.31 (-5%) info
Market Cap: $3.801B info
RNST
May 07, 2026, 5:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $40.18
Real-time Price: $41.58 info
Change: +$1.40 (+3%) info
Market Cap: $3.801B info